Endoscopic suturing for gastroesophageal reflux disease: Clinical outcome with the Bard EndoCinch

Richard I. Rothstein, Charles Filipi

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

From a review of the single peer reviewed published report and the brief preliminary studies presented in abstract form, the BARD EndoCinch procedure seems safe and demonstrates an acceptable efficacy for symptom control during short-term follow-up. Most patients (about 2 out of 3) do well with improvement of GERD symptoms during the first post-procedural year. This benefit may wane over time. Objective benefit is lacking with the minority of treated individuals achieving normalization of 24-hour total acid exposure, and no significant effect has been seen in healing of esophagitis. This may focus the treatment towards that group of GERD patients with mild or non-erosive disease. The authors have no information that the endoscopic therapy could prevent reflux-related complications, and long-term data is awaited from accumulated clinical experience to establish the maintenance profile of this novel treatment. The outcomes from the sham trial, and long-term follow-up data will help to define the role of this antireflux therapy. The authors need additional studies to define the effect of endoluminal plication on the function of the lower esophageal sphincter to optimize its benefit for patients.

Original languageEnglish
Pages (from-to)89-101
Number of pages13
JournalGastrointestinal Endoscopy Clinics of North America
Volume13
Issue number1
DOIs
StatePublished - Jan 2003

Fingerprint

Gastroesophageal Reflux
Lower Esophageal Sphincter
Peer Review
Esophagitis
Therapeutics
Maintenance
Acids

All Science Journal Classification (ASJC) codes

  • Gastroenterology
  • Surgery

Cite this

Endoscopic suturing for gastroesophageal reflux disease : Clinical outcome with the Bard EndoCinch. / Rothstein, Richard I.; Filipi, Charles.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 13, No. 1, 01.2003, p. 89-101.

Research output: Contribution to journalReview article

@article{63021aef9f85406ea1779bd7dbd765fb,
title = "Endoscopic suturing for gastroesophageal reflux disease: Clinical outcome with the Bard EndoCinch",
abstract = "From a review of the single peer reviewed published report and the brief preliminary studies presented in abstract form, the BARD EndoCinch procedure seems safe and demonstrates an acceptable efficacy for symptom control during short-term follow-up. Most patients (about 2 out of 3) do well with improvement of GERD symptoms during the first post-procedural year. This benefit may wane over time. Objective benefit is lacking with the minority of treated individuals achieving normalization of 24-hour total acid exposure, and no significant effect has been seen in healing of esophagitis. This may focus the treatment towards that group of GERD patients with mild or non-erosive disease. The authors have no information that the endoscopic therapy could prevent reflux-related complications, and long-term data is awaited from accumulated clinical experience to establish the maintenance profile of this novel treatment. The outcomes from the sham trial, and long-term follow-up data will help to define the role of this antireflux therapy. The authors need additional studies to define the effect of endoluminal plication on the function of the lower esophageal sphincter to optimize its benefit for patients.",
author = "Rothstein, {Richard I.} and Charles Filipi",
year = "2003",
month = "1",
doi = "10.1016/S1052-5157(02)00107-1",
language = "English",
volume = "13",
pages = "89--101",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Endoscopic suturing for gastroesophageal reflux disease

T2 - Clinical outcome with the Bard EndoCinch

AU - Rothstein, Richard I.

AU - Filipi, Charles

PY - 2003/1

Y1 - 2003/1

N2 - From a review of the single peer reviewed published report and the brief preliminary studies presented in abstract form, the BARD EndoCinch procedure seems safe and demonstrates an acceptable efficacy for symptom control during short-term follow-up. Most patients (about 2 out of 3) do well with improvement of GERD symptoms during the first post-procedural year. This benefit may wane over time. Objective benefit is lacking with the minority of treated individuals achieving normalization of 24-hour total acid exposure, and no significant effect has been seen in healing of esophagitis. This may focus the treatment towards that group of GERD patients with mild or non-erosive disease. The authors have no information that the endoscopic therapy could prevent reflux-related complications, and long-term data is awaited from accumulated clinical experience to establish the maintenance profile of this novel treatment. The outcomes from the sham trial, and long-term follow-up data will help to define the role of this antireflux therapy. The authors need additional studies to define the effect of endoluminal plication on the function of the lower esophageal sphincter to optimize its benefit for patients.

AB - From a review of the single peer reviewed published report and the brief preliminary studies presented in abstract form, the BARD EndoCinch procedure seems safe and demonstrates an acceptable efficacy for symptom control during short-term follow-up. Most patients (about 2 out of 3) do well with improvement of GERD symptoms during the first post-procedural year. This benefit may wane over time. Objective benefit is lacking with the minority of treated individuals achieving normalization of 24-hour total acid exposure, and no significant effect has been seen in healing of esophagitis. This may focus the treatment towards that group of GERD patients with mild or non-erosive disease. The authors have no information that the endoscopic therapy could prevent reflux-related complications, and long-term data is awaited from accumulated clinical experience to establish the maintenance profile of this novel treatment. The outcomes from the sham trial, and long-term follow-up data will help to define the role of this antireflux therapy. The authors need additional studies to define the effect of endoluminal plication on the function of the lower esophageal sphincter to optimize its benefit for patients.

UR - http://www.scopus.com/inward/record.url?scp=0037243971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037243971&partnerID=8YFLogxK

U2 - 10.1016/S1052-5157(02)00107-1

DO - 10.1016/S1052-5157(02)00107-1

M3 - Review article

C2 - 12797429

AN - SCOPUS:0037243971

VL - 13

SP - 89

EP - 101

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 1

ER -